• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.

作者信息

Jrgensen A, Overø K F

出版信息

Acta Psychiatr Scand Suppl. 1980;279:41-54. doi: 10.1111/j.1600-0447.1980.tb07082.x.

DOI:10.1111/j.1600-0447.1980.tb07082.x
PMID:6931472
Abstract

Serum concentrations of clopenthixol and flupenthixol have been determined during a four weeks dosage interval in patients treated with intramuscular injections of clopenthixol decanoate or flupenthixol palmitate in Viscoleo. Maximal drug levels were attained by the end of the first week after injection of either preparation. A period of exponential decline was then recorded. The half-lives were estimated to 19 days for clopenthixol and 17 days for flupenthixol. These half-lives most likely refer to the rate of release from the oil depot and not to elimination of drug. The mean ratio between maximal and minimal drug levels was 2.5 for clopenthixol and 3.7 for flupenthixol. Systemic clearance was estimated to about 0.7 l/min and 0.5 l/min, respectively. Significant correlation was found between the administered doses and recorded serum levels, between doses and estimated areas under the serum concentration curves, and also between areas and drug levels. The data indicate more limited individual variability than that seen with other psychotropic drugs, given orally. The study clearly demonstrates, that significant serum levels of active drug is maintained throughout the dosage interval by intramuscular injection of clopenthixol decanoate or flupenthixol palmitate in Viscoleo every fourth week.

摘要

相似文献

1
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Acta Psychiatr Scand Suppl. 1980;279:41-54. doi: 10.1111/j.1600-0447.1980.tb07082.x.
2
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.门诊精神分裂症患者中氯哌噻吨和氟哌噻吨长效制剂。IV. 血清水平与临床疗效。
Acta Psychiatr Scand Suppl. 1980;279:55-63. doi: 10.1111/j.1600-0447.1980.tb07083.x.
3
A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
Acta Psychiatr Scand Suppl. 1980;279:92-103. doi: 10.1111/j.1600-0447.1980.tb07086.x.
4
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Acta Psychiatr Scand Suppl. 1980;279:10-28. doi: 10.1111/j.1600-0447.1980.tb07080.x.
5
Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo to schizophrenic patients.
Psychopharmacology (Berl). 1979 Sep;65(1):69-72. doi: 10.1007/BF00491981.
6
Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Psychopharmacology (Berl). 1984;83(2):147-50. doi: 10.1007/BF00429723.
7
Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.
Psychopharmacology (Berl). 1983;81(1):68-72. doi: 10.1007/BF00439276.
8
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.门诊精神分裂症患者中氯哌噻吨和氟哌噻吨长效制剂。II. 精神分裂症CPRS子量表的因子分析
Acta Psychiatr Scand Suppl. 1980;279:29-40. doi: 10.1111/j.1600-0447.1980.tb07081.x.
9
Clinical pharmacokinetics of the depot antipsychotics.长效抗精神病药物的临床药代动力学
Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003.
10
Fluctuation of serum zuclopenthixol concentrations in patients treated with zuclopenthixol decanoate in viscoleo.
Ther Drug Monit. 1994 Apr;16(2):155-9. doi: 10.1097/00007691-199404000-00008.

引用本文的文献

1
Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia-a systematic review of the literature.估算氟奋乃静癸酸酯在精神分裂症维持治疗中的最佳剂量——文献系统评价。
Psychopharmacology (Berl). 2019 Nov;236(11):3081-3092. doi: 10.1007/s00213-019-05311-2. Epub 2019 Jul 12.
2
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.癸酸氟哌噻吨(长效制剂)用于治疗精神分裂症或其他类似的精神障碍。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD001470. doi: 10.1002/14651858.CD001470.pub2.
3
Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents.
药物制剂对纯化的猪和人肝脏视黄酯水解酶的抑制作用。
Lipids. 2001 May;36(5):543-8. doi: 10.1007/s11745-001-0755-z.
4
Depot antipsychotic drugs. Place in therapy.长效抗精神病药物。在治疗中的应用。
Drugs. 1994 May;47(5):741-73. doi: 10.2165/00003495-199447050-00004.
5
Pharmacokinetic studies in volunteers of intravenous and oral cis (Z)-flupentixol and intramuscular cis (Z)-flupentixol decanoate in Viscoleo.在志愿者中进行的静脉注射和口服顺式(Z)-氟哌噻吨以及在Viscoleo中肌肉注射顺式(Z)-氟哌噻吨癸酸酯的药代动力学研究。
Eur J Clin Pharmacol. 1980 Oct;18(4):355-60. doi: 10.1007/BF00561395.
6
Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.接受氟哌噻吨癸酸酯和顺式(Z)-氟哌噻吨治疗的慢性精神分裂症患者血清中顺式(Z)-氟哌噻吨和催乳素的浓度。
Psychopharmacology (Berl). 1982;77(1):58-65. doi: 10.1007/BF00436100.
7
Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.
Psychopharmacology (Berl). 1983;81(1):68-72. doi: 10.1007/BF00439276.
8
Steady-state serum concentrations after cis (Z)-flupentixol decanoate in viscoleo.
Psychopharmacology (Berl). 1983;80(4):371-3. doi: 10.1007/BF00432123.
9
Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Psychopharmacology (Berl). 1984;83(2):147-50. doi: 10.1007/BF00429723.
10
Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.长效抗精神病药物治疗期间口面部迟发性运动障碍的变化
Psychopharmacology (Berl). 1983;81(4):359-62. doi: 10.1007/BF00427579.